Osteoarthritis and Cartilage Open (Sep 2021)

Study protocol for the follow-up examination of the Nor-Hand study: A hospital-based observational cohort study exploring pain and biomarkers in people with hand osteoarthritis

  • Marthe Gløersen,
  • Pernille Steen Pettersen,
  • Øystein Maugesten,
  • Elisabeth Mulrooney,
  • Alexander Mathiessen,
  • Heidi Gammelsrud,
  • Hilde Berner Hammer,
  • Tuhina Neogi,
  • Sarah Ohrndorf,
  • Karwan Faraj,
  • Dag Sjølie,
  • Barbara Slatkowsky-Christensen,
  • Tore Kristian Kvien,
  • Ida Kristin Haugen

Journal volume & issue
Vol. 3, no. 3
p. 100198

Abstract

Read online

Objective: This study aims to increase the understanding of pain mechanisms in hand OA and explore potential risk factors for pain development or worsening in a biopsychosocial framework. Another important aim is to validate potential soluble and imaging OA biomarkers. Design: The follow-up examination of the Nor-Hand hospital-based observational cohort study started in October 2019 and was completed in May 2021. In total, 212 of the 300 participants with hand OA who were examined at baseline attended the follow-up study. The participants underwent clinical joint examinations, medical and functional assessments, quantitative sensory testing, fluorescence optical imaging, ultrasound of the hands, acromioclavicular joints, feet, knees and hips, conventional radiographs of the hands and feet and magnetic resonance imaging of the dominant hand. Blood and urine samples were collected, and all participants answered questions about demographic factors and OA-related questionnaires. Associations between disease variables and symptoms will be examined in cross-sectional and longitudinal analyses. Longitudinal analyses will be performed to assess the predictive value of baseline variables on hand OA outcomes. Conclusion: Current knowledge about predictors for disease progression in hand OA is limited, but with longitudinal data we will be able to explore the predictive value of baseline variables on hand OA outcomes, such as changes in patient-reported outcomes or changes in soluble and imaging biomarkers. This provides a unique opportunity to gain more knowledge about the natural disease course of hand OA.

Keywords